ArticleFrontiers in oncology2023

Immunotherapy strategies for EGFR-mutated advanced NSCLC after EGFR tyrosine-kinase inhibitors failure.

Xingyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.